As of December 31, 2025, ViVeTech Nyrt. carries a market capitalization of 3.68B, placing it among publicly traded companies globally. Its enterprise value stands at 3.71B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.68B |
| Enterprise Value | 3.71B |
As of December 31, 2025, ViVeTech Nyrt. has 12.36M shares outstanding.
| Shares Outstanding | 12.36M |
These figures are as of December 31, 2025.
| PB Ratio | 4.19 |
| P/TBV Ratio | 6.24 |
As of December 31, 2025, ViVeTech Nyrt. maintains a current ratio of 1.98, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.98 |
| Quick Ratio | 0.37 |
| Debt / Equity | 22.88 |
As of the close on October 21, 2026, ViVeTech Nyrt.'s stock has declined approximately 2.58% over the past 52 weeks. The 50-day moving average sits at 277.48, while the 200-day moving average is 289.20.
| 52-Week Price Change | -2.58% |
| 50-Day Moving Average | 277.48 |
| 200-Day Moving Average | 289.20 |
As of December 31, 2025, ViVeTech Nyrt. holds 169.70M in cash and equivalents against 201.25M in total debt, resulting in a net debt position of 31.55M. Total book value stands at 879.70M, with working capital of 453.23M providing operational flexibility.
| Cash & Cash Equivalents | 169.70M |
| Total Debt | 201.25M |
| Net Debt | 31.55M |
| Equity (Book Value) | 879.70M |
| Book Value Per Share | 71.20 |
| Working Capital | 453.23M |
Already premium?